MIRA Pharmaceuticals, Inc. (MIRA)
NASDAQ·Healthcare·Drug Manufacturers - General
$1.02
+0.00%
Mkt Cap $48.58M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 31, 2026 | — | — | — | -$0.04 | -$0.15 | -275.00% | — | — |
| Q4 2025 Nov 13, 2025 | — | — | — | -$1.18 | -$1.18 | +0.00% | — | — |
| Q3 2025 Aug 14, 2025 | — | — | — | -$0.11 | -$0.09 | +18.18% | — | — |
| Q2 2025 May 14, 2025 | — | — | — | -$0.15 | -$0.11 | +26.67% | — | — |
| Q1 2025 Mar 28, 2025 | — | $11.16M | — | -$0.29 | -$0.15 | +48.28% | — | — |
| Q4 2024 Nov 12, 2024 | — | — | — | -$0.18 | -$0.14 | +22.22% | — | — |
| Q3 2024 Aug 13, 2024 | — | — | — | -$0.10 | -$0.11 | -10.00% | — | — |
| Q2 2024 May 13, 2024 | — | — | — | -$0.10 | -$0.12 | -20.00% | — | — |
| Q2 2024 Apr 1, 2024 | — | — | — | -$0.23 | -$0.39 | -70.23% | — | — |
| Q4 2023 Nov 13, 2023 | — | — | — | -$0.08 | -$0.26 | -225.00% | — | — |
| Q3 2023 Sep 15, 2023 | — | — | — | — | -$0.10 | — | — | — |
| Q1 2023 Mar 31, 2023 | — | — | — | — | -$0.09 | — | — | — |
| Q4 2022 Dec 31, 2022 | — | — | — | — | -$43.86 | — | — | — |
| Q3 2022 Sep 30, 2022 | — | — | — | — | -$0.12 | — | — | — |
| Q2 2022 Jun 30, 2022 | — | — | — | — | -$0.16 | — | — | — |
| Q1 2022 Mar 31, 2022 | — | — | — | — | -$0.10 | — | — | — |
| Q1 2021 Mar 31, 2021 | — | — | — | — | -$0.00 | — | — | — |